Jewish-Catholic relations, Jewish Studies

Adam Gregerman, Ph.D., is an associate professor of Jewish Studies in the Department of Theology and Religious Studies and Associate Director of the Institute for Jewish-Catholic Relations at Saint Joseph’s University. His research focuses on the complex relationship between Jews and Christians from antiquity to the present. He published Building on the Ruins of the Temple: Apologetics and Polemics in Early Christianity and Rabbinic Judaism (Mohr Siebeck, 2016). His articles on biblical interpretation, mission and conversion, rabbinic theology, religious polemics, and theologies of the land of Israel have appeared in journals such as Theological Studies, Modern Theology, Interpretation, Cross Currents, Journal of Ecumenical Studies, and Studies in Christian-Jewish Relations. Dr. Gregerman has presented lectures in diverse settings, including academic conferences, synagogues, churches, and community centers, and taught in seminaries and universities.

He is a member of the Committee on Ethics, Religion, and the Holocaust at the U.S. Holocaust Memorial Museum, Vice-Chair of the Council of Centers on Jewish-Christian Relations, and Academic Advisor to the National Council of Synagogues.

Urban Principals, Faculty careers, Women Faculty Advancement, K-12 Teaching and Learning, Higher Education Teaching and Learning

Aimee LaPointe Terosky, Ed.D., is an associate professor of educational leadership at Saint Joseph's University and the Director of the IDEPEL Doctoral Program. Dr. Terosky teaches courses in K-12 and Higher Education leadership at the doctoral and masters levels. Prior to her arriving at Saint Joseph's in January 2011, Dr. Terosky was an adjunct assistant professor of higher and postsecondary education at Teachers College, Columbia University, where she taught courses on teaching and learning and faculty development in postsecondary education settings. From 2006-2011, she also served as the assistant principal of Public School #334, The Anderson School in New York City, which received the 2007 New York City Blackboard Award for Outstanding Public Middle School. Areas of expertise: urban principals, faculty careers, women faculty advancement, K-12 and higher education teaching and learning

Appetite, Obesity, Parkinson's Disease, Brain Imaging, music and the mind

Dr. Alain Dagher is a neurologist specializing in movement disorders and functional brain imaging. His research aims at understanding the function of the basal ganglia, with a particular emphasis on appetitive behaviours. This involves studying how we learn about rewards and punishments, and become motivated to engage in reward-seeking behaviour. The two main techniques used are positron emission tomography (PET) targeting the dopamine system, and functional magnetic resonance imaging (fMRI). The research focusses on Parkinson's Disease, stress, drug addiction (notably cigarette smoking), pathological gambling, and obesity. Dr. Dagher is funded by CIHR, FRSQ, NIDA, the Parkinson Society of Canada, the Institute for Research on Pathological Gambling and Related Disorders, and Unilever PLC.

Aldona Spiegel

Director, Houston Methodist Center for Breast Restoration

Houston Methodist


Dr. Aldona Spiegel certified in plastic surgery by the American Board of Plastic Surgery. She completed her medical training at the University of Ottawa Faculty of Medicine. Spiegel completed a residency in general surgery and plastic surgery at John Hopkins Hospital. She also completed a residency in plastic surgery and a fellowship in microsurgery at Baylor College of Medicine. Spiegel's clinical focus is microsurgery, breast reconstruction, breast sensation and specialized perforator flaps (DIEP, SIEA, SGAP flaps). Her clinical expertise allows her to focus on research in innovative surgical techniques, such as muscle-preserving flaps.

Alessandro Grattoni

Chair, Houston Methodist Research Institute Department of Nanomedicine

Houston Methodist


Alessandro Grattoni obtained his bachelor's and master's degrees in Mechanical Engineering at the Politecnico of Torino. Grattoni also completed a Postdoctoral Fellowship in nanomedicine and biomedical engineering at The University of Texas Health Science Center. His research focuses on the development and clinical translation of implantable nanofluidic technologies for drug delivery, molecular sieving and cell transplantation. Grattoni areas of expertise are nanomedicine, nanofluidics, drug delivery, implantable devices, silicon technologies, and space medicine.

Ali Tabrizchi

Interventional cardiologist

LifeBridge Health

Cardiovascular Disease, Lifebridge Health, Sinai Hospital, Cardiovascular Institute, Angiograms, Coronary Artery Disease, nuclear stress tests, Echocardiogram, Heart Failure, Heart Disease

Dr. Tabrizchi is a clinical interventional cardiologist at the LifeBridge Health Cardiovascular Institute in Maryland. He completed his fellowship at Winthrop-University Hospital. He did his residency at Washington Hospital Center, Children’s National Medical Center and National Institutes of Health (NIH). He completed medical school at Nova Southeastern University of College of Osteopathic Medicine. Dr. Tabrizchi is published in national and international medical journals.

Mental Health, Depression, Anxiety, Eating Disorders, PTSD, Insomnia, Sleep Disorders, Psychology

Dr. Amit Shahane, PhD, is a clinical psychologist who serves as the director of the Behavioral Medicine Center at the University of Virginia Health System. Dr. Shahane specializes in treating psychological disorders, including PTSD, that impact medical illness. His research interests include examining the effectiveness of cognitive and behavioral treatments for insomnia, as well as healthcare utilization research, such as the effect of HIV stigma.

UVA's Behavioral Medicine Center diagnoses, treats and prevents medical problems either caused or aggravated by lifestyle or stress, including:
•	Depression and anxiety
•	Migraine and tension headaches
•	Nervous stomach and irritable bowel syndrome
•	Sleep problems
•	Eating disorders

Listen to Shahane discuss sleep problems:

Shahane discusses PTSD:

Amr Moursi

Professor and Chair of Pediatric Dentistry

New York University

Pediatric Dentistry, Dentistry, Dentistry and children, Oral Health

Amr M. Moursi, DDS, PhD, is a professor and chair of the Department of Pediatric Dentistry at NYU College of Dentistry. His research focuses on early childhood oral health, including the use of silver diamine fluoride (SDF) to fight cavities, birth defects of the head and skull, nutrition and oral health, and developing the pediatric dentistry workforce.

Dr. Moursi is the author or co-author of more than 100 published articles, book chapters, and policy briefs, and is the editor of the textbook "Clinical Cases in Pediatric Dentistry" (Wiley-Blackwell). He is also a contributor for the 2020 U.S. Surgeon General’s Report on Oral Health. 

Dr. Moursi is a board-certified diplomate of the American Board of Pediatric Dentistry.  He serves on the Executive Committee and as a National Spokesperson for the American Academy of Pediatric Dentistry (AAPD). He has extensive experience with print and broadcast media and is host of "The Dental Health Show" on Doctor Radio, SiriusXM satellite radio. 

Watch Dr. Moursi on ABC 7 discussing how to keep baby teeth healthy:

PTSD, Brain Function, Attention Training, National Science Foundation, NSF, MEG

Dr. Badura Brack teaches Abnormal, Health, and Introductory Psychology, and she supervises the psychology internship program at Creighton University. Dr. Badura Brack is developing and testing a version of Attention Training Treatment that appears efficacious in treating combat-related Posttraumatic Stress Disorder (PTSD), as well as using magnetoencephalography (MEG) to identify regions where the brain functions abnormally in PTSD and determine if more normal neural functioning can be restored after attention training treatment.

Amy McMichael

Professor, Dermatology

Wake Forest Baptist Health

Hair and Scalp Disease, Ethnic and Pigmented Skin Disease, Epidemiology of Skin Disease, Skin Care, Dermatology, Skin Cancer, Cosmetic Dermatology

McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.

Andrei Gudkov

Senior Vice President of Basic Science and the Gar

Roswell Park Comprehensive Cancer Center

Cancer Genetics, Cancer Therapies, Drug Discovery, Radiation effects

Senior Vice President of Basic Science and the Garman Family Chair in Cell Stress Biology, Roswell Park Cancer Institute
Areas of expertise: Cancer genetics, new cancer therapies, drug discovery, effects of radiation

Tobacco, Tobacco Control, tobacco policy, Epidemiologic, Public Health, e-cigarretes, vaping

Chair of Health Behavior, Roswell Park Cancer Institute
Areas of expertise:  Tobacco, tobacco control, tobacco policy, epidemiology, public health, e-cigarettes, vaping

Andrew Pavia

Professor of Pediatrics

University of Utah Health

Infectious Disease, Influeza

Andrew Pavia, MD, is a professor of Pediatrics at University of Utah Health and Chief of the Division of Pediatric Infectious Diseases and Director of Hospital Epidemiology, Primary Children's Medical Center. His interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. 

He is keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s. Dr. Pavia has over 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. 

Prescription Drug Cost, video game industry, Banking, behavior analysis, peer-to-peer, Lending, Economics, Marketing, Management Science, Nursing Home, Econometrics

Andrew Ching is a professor in the Carey Business School at the Johns Hopkins University, where he is jointly appointed to the Department of Economics and the Bloomberg School of Public Health.  He is currently serving as an Associate Editor for Management Science, and a member of editorial boards for Marketing Science and Journal of Marketing Research.  His research focuses on developing new empirical structural models and estimation methods to understand the forward-looking, strategic, learning and bounded rational behavior of consumers and firms.  He has applied these methods to several industries including prescription drugs, nursing homes, payment methods, retail banking, peer-to-peer lending, and video games. He has published in Econometrica, Mangement Science, Marketing Science, Journal of Banking and Finance, Journal of Applied Econometrics, and others. He has received Young Economist Award from the European Economic Association, Honorable Mention of Dick Wittink Prize Award, and several major research grants from Social Sciences and Humanities Research Council in Canada.

Oncologist, Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma), Blood Disorders, Blood Cancer, Leukemia, Hematology

Dr. Andrew M. Evens is a physician-scientist at the Rutgers Cancer Institute of New Jersey, where he is Associate Director for Clinical Services and Director of the Lymphoma Program. In addition, he is the Medical Director of the Oncology Service Line for the RWJBarnabas Health system. Dr. Evens completed a Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, where he was also Director of Translational Therapeutics. Prior to his Rutgers Cancer Institute appointment, Dr. Evens served as Chief of the Division of Hematology/Oncology at Tufts Medical Center and as Director of the Tufts Cancer Center in Boston, MA.

Dr. Evens is an associate editor for the British Journal of Haematology and serves on the editorial board for the Journal of Clinical Oncology. He is a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and has been a member of several clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group.  Dr. Evens is also an elected member of the Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and he is involved in multiple national and international educational forums and events.

I completed a prior fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where I also remained as a faculty member altogether for 10 years. Most recently, I served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology, and Professor of Medicine at Tufts University School of Medicine.

My clinical expertise and research interests are fully dedicated to the field of lymphoma (i.e., Hodgkin lymphoma and non-Hodgkin lymphoma). Over the past 15+ years, I have been the principal investigator of more than 80 national and international cancer clinical trials that have included phase I, II, and III studies, many which have been “investigator-initiated” trials studying new and novel targeted agents for the treatment of lymphoid malignancies. In addition to my clinical research, I also manage a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients. Collectively, my research has been continuously funded by the National Institutes of Health (NIH) and the NCI since 2005. This has resulted in 200+ research abstracts at national and international cancer research symposiums, 150+ manuscripts in peer-reviewed publications, and 20+ book chapters all with an emphasis on the biology, prognosis, and treatment of lymphoma.

My involvement in the advancement of cancer research has also included leadership roles in academic journals, symposiums, cancer advocacy groups, and international committees. I was an associate editor for the British Journal of Haematology and on the editorial board for the Journal of Clinical Oncology and am the inaugural editor in chief for the open access journal, eJHaem. I am a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and I have been a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. Furthermore, I am Co-Chair of the Lymphoma Committee for the ECOG-ACRIN cancer research group and am honored to be an elected member of the North American Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and a member of the Board of Trustees for the Leukemia & Lymphoma Society (LLS) New Jersey Chapter. Finally, I am involved and help lead a multitude of regional, national, and international educational forums and events.

Associate Director for Clinical Services at Rutgers Cancer Institute of New Jersey
Medical Director of the Oncology Service Line, RWJBarnabas Health
Director, Lymphoma Program, Division of Blood Disorders

Clinical Expertise:
Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation.

Research Interests:
Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)
Chronic lymphocytic leukemia and other lymphoid malignancies
Clinical trials
Translational studies, including lymphoma biology and drug discovery
Systems biology and biomarker analyses
Lymphoma epidemiology
Health Outcomes, including Pharmacovigilance and Decision Making

I am thrilled to be a member of the Rutgers Cancer Institute of New Jersey (CINJ) as the Associate Director for Clinical Services, Medical Director of the Oncology Service Line for RWJBarnabas Health, and Director of the Lymphoma Program. Rutgers Cancer Institute is unique in that it is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center. Our mission is to deliver integrated cancer care across the health system with access to academic expertise and innovative cancer therapies not available elsewhere in the state.

Medicine, Pediatric, Infectious Diseases, Internal Medicine, pediatric infectious diseases, Preventive Medicine, HIV

Dr. Pavia received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public Health Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980s.

Anees Chagpar

Associate Professor; Director, Assistant Director

Yale Cancer Center

Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare

Anees is the Director of The Breast Center, Smilow Cancer Hospital at Yale-New Haven, an Associate Professor in the Department of Surgery, Yale School of Medicine, and the Assistant Director for Global Oncology at Yale Comprehensive Cancer Center. Born and

Angela Alistar MD

Medical Director, GI Medical Oncology, Morristown Medical Center

Atlantic Health System

Gastrointestinal Cancer, Pancreatic Cancer, Clinical Trials, gi medical oncology researcher, Precision Oncology, Immunotherapy, inmmuno-oncology, cancer metabolism

Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group.  Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the Phase 1 Breakthrough Treatment Center.  Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involved active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.

Recently, she has published in Lancet Oncology the results of a Phase 1 clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.

Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.

Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the "Danny Danielson Translational Innovation Award" by Hoosier Cancer Research Network for her commitment to clinical research. 

She received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed a hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.

Ann Morning

Associate Professor, Sociology

New York University


Ann Morning, author of The Nature of Race: How Scientists Think and Teach about Human Difference (University of California), is an associate professor of sociology at New York University. She is a member of the U.S. Census Bureau National Advisory Committee on Racial, Ethnic, and Other Populations and has served as a statistician for the bureau. Morning has also authored reports for the National Research Council’s Committee on the Use of Social Science Knowledge in Public Policy and the United Nations’ Statistics Division. Morning is also the academic director of 19 Washington Square North, NYU Abu Dhabi’s home in New York.

Morning previously worked as an economist at the Federal Reserve Bank of New York and as a diplomat in the U.S. Foreign Service. From 1995 to 1997, she was an Assistant Dean for Academic Affairs at Columbia University’s School of International and Public Affairs.

Morning received her B.A. magna cum laude from Yale, her Master’s in International Affairs from Columbia, and her Ph.D. in sociology from Princeton. She also studied at the Institut d’Etudes Politiques in Paris.

African-American History, African Diaspora, History and Memory, African History, Civil Rights, Oral History, Race, Slavery, Immigration, Refugees, Human Rights

Bailey’s research interests include African-American history; African and African Diaspora studies; history and memory; oral history; and civil rights.   She writes and speaks about a variety of topics related to these research areas, including race, slavery, immigration, refugees, diasporas, faith and history and human rights.
 In her work, Bailey combines the elements of travel, adventure, history and an understanding of contemporary issues with an accessible style. Her works range from adult non-fiction to children’s historical fiction, and includes African Voices of the Atlantic Slave Trade: Beyond the Silence and the Shame (Beacon Press, 2005) and You Can Make A Difference: The Story of Martin Luther King Jr. (Bantam/Doubleday/Dell). Her newest book, The Weeping Time: Memory and the Largest Slave Auction in American History, was published by Cambridge University Press in October 2017 and has received very wide coverage.
Chat now!